Articles

Low levels of vitamin D have been recently linked with glucose intolerance, type 2 diabetes, insulin resistance, hypertension, hyperlipidemia, and CV disease…. 

A 6-year lifestyle intervention decreased the incidence of diabetes, cardiovascular mortality, and all-cause mortality in adults with impaired glucose tolerance…. 

A lower percentage of type 2 diabetes cases are going undiagnosed than was the case in the past couple of decades, researchers found…. 

Diabetic patients who are depressed may be at an increased risk for developing end-stage renal disease…. 

Non-alcoholic fatty liver disease (NAFLD) is an independent predictor of both type 2 diabetes and carotid atherosclerosis, according to two studies…. 

Women with diabetes were 14% less likely than those without the disease to undergo breast cancer screening…. 

The American Heart Association questions the findings of a new analysis suggesting that most people around the world are consuming just the right amount of sodium…. 

Circulating levels of vitamin D had no apparent influence on overall risk for cardiovascular disease in older men…. 

The Food and Drug Administration (FDA) has approved albiglutide (Tanzeum, GlaxoSmithKline), a once-weekly injectable glucagonlike peptide 1 (GLP-1) receptor agonist to treat type 2 diabetes…. “Tanzeum is a new treatment option for the millions of Americans living with type 2 diabetes,” Curtis Rosebraugh, MD, MPH, director of the Office of …

A new study by a University of Miami (UM) researcher analyzed nearly three decades of data on the effect of chromium supplementation on blood sugars….